Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.020 Biomarker disease BEFREE We suggest that genes within the RAS-MAPK and PI3-AKT pathways might have a significant role in the pathogenesis of CIM in such patients. 28286253 2017
Entrez Id: 207
Gene Symbol: AKT1
AKT1
0.020 Biomarker disease BEFREE Along with the recent literature evidence, we suppose that interactions between FGFR and RAS/MAPK pathway and between RAS/MAPK and PTEN-PI3K/AKT pathways could explain some phenotypic overlapping features and could have a significant role in the pathogenesis of CMI. 31363831 2019
Entrez Id: 8854
Gene Symbol: ALDH1A2
ALDH1A2
0.010 Biomarker disease BEFREE None of these overcame corrections for multiple comparisons, in contrast with four SNPs in CDX1, FLT1 and ALDH1A2 in the classical CMI group. 23437350 2013
Entrez Id: 657
Gene Symbol: BMPR1A
BMPR1A
0.010 Biomarker disease BEFREE Single-marker analysis identified nominal associations with 18 SNPs in 14 genes (CDX1, FLT1, RARG, NKD2, MSGN1, RBPJ1, FGFR1, RDH10, NOG, RARA, LFNG, KDR, ALDH1A2, BMPR1A) considering the whole CMI sample. 23437350 2013
Entrez Id: 962
Gene Symbol: CD48
CD48
0.010 Biomarker disease BEFREE The period prevalence in the entire RT for symptomatic CM1 was 20:100 000; for bCM1 was 10:100 000; and for CM1 and bCM1 together was 30:100 000. 29788393 2019
Entrez Id: 8318
Gene Symbol: CDC45
CDC45
0.100 Biomarker disease HPO
Entrez Id: 1044
Gene Symbol: CDX1
CDX1
0.010 GeneticVariation disease BEFREE Multiple marker analysis identified a risk haplotype for classical CMI in ALDH1A2 and CDX1. 23437350 2013
Entrez Id: 1387
Gene Symbol: CREBBP
CREBBP
0.010 Biomarker disease BEFREE In the present report, we describe a case of a 2-year-old female with RSTS who, besides most of the typical features of RSTS has corpus callosum dysgenesis and a Chiari type I malformation which required neurosurgical decompression. 20101707 2010
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 Biomarker disease BEFREE The characteristic cerebellar tonsil herniation at the foramen magnum may either cause raised ICP by disturbing CSF flow (as observed in idiopathic CM1) or may itself be the effect of raised ICP (as observed in acquired CM1). 31197535 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 Biomarker disease BEFREE In the case of IIH and Chiari I malformation, children who have recurrent symptoms despite adequate posterior fossa decompression surgery (failed Chiari), there is a strong role for intracranial pressure monitoring as raised intracranial pressure may indicate long-term CSF diversion. 31203396 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE There was a significant negative correlation between the percentage change in CSF stroke volume (resting to postcoughing) and Chiari I malformation disease severity (<i>R</i> = 0.59; <i>P</i> = .03). 29748208 2018
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE A "complex" hypothesis, on the other hand, can explain the occurrence of hydrocephalus and CIM because of the venous engorgement resulting from the hypoplasia of the posterior cranial fossa (PCF) and the occlusion of the jugular foramina, leading to cerebellar edema (CIM) and CSF hypo-resorption (hydrocephalus). 31227858 2019
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE METHODS A semiautomated segmentation program was developed, and used to compare the pre- and postoperative volumes of the posterior cranial fossa (PCF) and the CSF spaces (cisterna magna, prepontine cistern, and fourth ventricle) in a cohort of pediatric patients with CM-I. 28291422 2017
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE METHODS Data from the clinical records of 82 symptomatic adult patients with CMI and altered hindbrain CSF flow who were managed with foramen magnum decompression, C-1 laminectomy, and duraplasty over an 8-year period were collected and analyzed. 29125433 2018
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE RESULTS No significant differences were observed between patients with symptomatic and asymptomatic CM-I related to tentorium length (50.3 vs 51.0 mm; p = 0.537), supraoccipital length (39.4 vs 42.6 mm; p = 0.055), clivus-tentorium distance (52.0 vs 52.1 mm; p = 0.964), clivus-torcula distance (81.5 vs 83.3 mm; p = 0.257), total posterior fossa volume (PFV; 183.4 vs 190.6 ml; p = 0.250), caudal PFV (152.5 vs 159.8 ml; p = 0.256), fourth ventricle volume to caudal PFV ratio (0.0140 vs 0.0136; p = 0.649), or CSF volume to caudal PFV ratio (0.071 vs 0.061; p = 0.138). 29125445 2018
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 AlteredExpression disease BEFREE Therefore, the authors sought to identify, characterize, and examine the intradural pathology and CSF flow pathophysiology in the posterior fossa and at the level of the foramen magnum that occurs in the setting of CM-I. 29027876 2017
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.090 GeneticVariation disease BEFREE OBJECTIVEIn patients with syringomyelia and type I Chiari malformation (CM-I) who have required reoperation because of persistent, recurrent, or expanding syrinx, the senior author placed a stent from the fourth ventricle to the cervical subarachnoid space in hopes of promoting circulation of CSF out of the ventricle and away from the central canal of the spinal cord. 30497207 2018
Entrez Id: 22943
Gene Symbol: DKK1
DKK1
0.410 GeneticVariation disease BEFREE Screening of DKK1 in a cohort of 65 CMI sporadic patients identified another missense variant, the c.359G>T (p.(R120L)), in two unrelated patients. 28513615 2017
Entrez Id: 22943
Gene Symbol: DKK1
DKK1
0.410 Biomarker disease HPO
Entrez Id: 22943
Gene Symbol: DKK1
DKK1
0.410 GermlineCausalMutation disease ORPHANET Screening of DKK1 in a cohort of 65 CMI sporadic patients identified another missense variant, the c.359G>T (p.(R120L)), in two unrelated patients. 28513615 2017
Entrez Id: 1788
Gene Symbol: DNMT3A
DNMT3A
0.100 Biomarker disease HPO
Entrez Id: 2077
Gene Symbol: ERF
ERF
0.300 Biomarker disease CTD_human Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. 23354439 2013
Entrez Id: 2253
Gene Symbol: FGF8
FGF8
0.010 Biomarker disease BEFREE The genes selected are involved in signalling gradients occurring during segmental patterning of the occipital somites (FGF8, Wnt, and retinoic acid pathways and from bone morphogenetic proteins or BMP, Notch, Cdx and Hox pathways) or in placental angiogenesis, sclerotome development or CMI-associated syndromes. 23437350 2013
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.110 GeneticVariation disease BEFREE A novel fibroblast growth factor receptor 2 mutation in Crouzon syndrome associated with Chiari type I malformation and syringomyelia. 12186468 2002
Entrez Id: 2263
Gene Symbol: FGFR2
FGFR2
0.110 Biomarker disease HPO